Bristol Myers Squibb

Bristol Myers Squibb At Bristol Myers Squibb, we work every day to transform patients’ lives through science.

This year, more than 300 colleagues rode over 6,000 miles to raise funds for cancer research in our annual ride — and ...
12/23/2025

This year, more than 300 colleagues rode over 6,000 miles to raise funds for cancer research in our annual ride — and in Japan, they were greeted by a rainbow in the middle of their trek. See more moments from the record-breaking ride our mission to transform the lives of patients impacted by cancer in every way we can: https://bit.ly/4aYskxO

12/18/2025

Every patient story deserves to be seen, heard and felt. We’ve unveiled a new art installation, created with patients whose journeys inspire us. This display celebrates courage, hope and resilience—honoring patients and inspiring us all to pursue better outcomes.

Putting patients at the center of everything we do goes beyond our day-to-day job responsibilities. After a steep journe...
12/18/2025

Putting patients at the center of everything we do goes beyond our day-to-day job responsibilities.

After a steep journey, our 12th global bike ride to advance cancer research culminated last week in Chile, where our colleagues in Latin America helped push the projected donation to nonprofits like the UICC - Union for International Cancer Control past $2 million this year. Learn more about their commitment to patients impacted by cancer: https://bit.ly/49hrQl9

12/17/2025

CAR T cell therapy is changing the way certain blood cancers are treated. We teamed up with science communicator and podcast host Alie Ward and CAR T cell therapy patient Marilyn to break down the science and share Marilyn’s personal experience. See their conversation and explore more at: https://bit.ly/3KW7Qex

Our recent FDA approval marks a significant breakthrough for patients living with relapsed or refractory marginal zone l...
12/05/2025

Our recent FDA approval marks a significant breakthrough for patients living with relapsed or refractory marginal zone lymphoma ( ).

Initial therapy for MZL often leads to remission but relapse is common. Now patients have a personalized therapy option, addressing an unmet need for patients living with this rare disease.

Learn more about MZL. https://bit.ly/4pOUU8W

12/05/2025

Thank you, oncologists!

We’re grateful for the precious moments oncologists help give back to patients and their families.

Our Time Back campaign celebrates life and emphasizes the critical role oncologists play in potentially allowing patients to experience key moments like a child's basketball game, a graduation, or a long-awaited vacation.

Learn more about how we’re giving thanks to the healthcare professionals who dedicate their lives to treating cancer: https://bit.ly/3XwzH7Z

The FDA has approved our first-in-class personalized therapy for patients living with relapsed or refractory marginal zo...
12/05/2025

The FDA has approved our first-in-class personalized therapy for patients living with relapsed or refractory marginal zone lymphoma (MZL).

This approval marks an important advancement for this patient population, offering a new option for patients with this rare disease. https://bit.ly/3Kq1BQ3

We partnered with science communicator and podcast host Alie Ward and CAR T cell therapy patient, Marilyn, to discuss th...
12/04/2025

We partnered with science communicator and podcast host Alie Ward and CAR T cell therapy patient, Marilyn, to discuss this treatment option that uses a patient’s own T cells to help fight certain blood cancers. Hear more of Marilyn’s personal experience at: https://bit.ly/445aYv3

11/15/2025

What if healthcare providers received the thanks and recognition they deserve?

Together we can build a world of gratitude for healthcare providers who go above and beyond to deliver exceptional care.

Thank you, Champions in Care, for your commitment to improving the lives of patients everywhere.

11/11/2025

This month, we are inspired by stories of resilience and hope from the community. Brandi was serving overseas in the U.S. Army when she was deployed for a new kind of battle she never expected: cancer.

Learn how she uses her experience to coach others in the cancer survivorship community on Survivorship Today. https://bit.ly/3X8cp7T

Address

Route 206 & Province Line Road
Princeton, NJ
08543

Website

http://www.bms.com/

Alerts

Be the first to know and let us send you an email when Bristol Myers Squibb posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category